Analysis of currently available data in cBioPortal showed that 6.9% of primary tumors (84 out of 1121) demonstrated SLIRP gene copy number loss while 11.4% of metastatic tumors (105 out of 918) demonstrated SLIRP gene copy number loss (Supplementary Information Table 1). This evidence concerns the gene SLIRP and metastatic neoplasm.